| PXNIX | VFWPX | PXNIX / VFWPX | |
| Total Expense Ratio | 0.45 | 0.03 | 1,500% |
| Annual Report Gross Expense Ratio | 0.45 | 0.03 | 1,500% |
| Fund Existence | 15 years | 15 years | - |
| Gain YTD | 3.112 | 4.210 | 74% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250000 | 100000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.6B | 78.2B | 2% |
| Annual Yield % from dividends | 2.65 | 3.10 | 86% |
| Returns for 1 year | 26.54 | 34.53 | 77% |
| Returns for 3 years | 47.45 | 46.09 | 103% |
| Returns for 5 years | 39.56 | 32.70 | 121% |
| Returns for 10 years | 123.12 | 110.03 | 112% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| VGVT | 76.40 | 0.12 | +0.15% |
| Vanguard Government Securities Actv ETF | |||
| ECML | 34.73 | N/A | N/A |
| Euclidean Fundamental Value ETF | |||
| ULST | 40.56 | -0.01 | -0.01% |
| State Street® Ultra Short Term Bond ETF | |||
| JULH | 24.95 | N/A | -0.02% |
| Innovator Premium Income 20 Bar ETF -Jul | |||
| XBI | 124.35 | -2.47 | -1.95% |
| State Street® SPDR® S&P® Biotech ETF | |||